Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus spinal dexmedetomidine for quality of spinal anesthesia in inguinal hernia surgery
IRCT20171030037093N23Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dexmedetomidine in inguinal hernia, sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Pain severity, Maximum sensory block and 3 more. Started Sep 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20171030037093N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N23.